Literature DB >> 33385295

ANCA testing: where are we now?

Milena Bond1, Filippo Fagni2, Augusto Vaglio3.   

Abstract

Mesh：

Substances：

Year:  2021        PMID： 33385295     DOI： 10.1007/s11739-020-02584-w

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  10 in total

1.  The effect of a symptom related "gating policy" on ANCA requests in routine clinical practice.

Authors:  D Sinclair; M Saas; J M Stevens
Journal:  J Clin Pathol       Date:  2004-02       Impact factor: 3.411

2.  Does a gating policy for ANCA overlook patients with ANCA associated vasculitis? An audit of 263 patients.

Authors:  D F Arnold; A Timms; R Luqmani; S A Misbah
Journal:  J Clin Pathol       Date:  2010-08       Impact factor: 3.411

3.  Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease.

Authors:  Martina M McGrath; Tamara Isakova; Helmut G Rennke; Ann M Mottola; Karen A Laliberte; John L Niles
Journal:  Clin J Am Soc Nephrol       Date:  2011-10-06       Impact factor: 8.237

4.  Clinical implications of ANCA positivity in a hospital setting: a tertiary center experience.

Authors:  Bashar Fteiha; Alon Bnaya; Marwan Abu Sneineh; Gideon Nesher; Gabriel Simon Breuer
Journal:  Intern Emerg Med       Date:  2020-10-06       Impact factor: 3.397

Review 5.  International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA)

Authors:  J Savige; D Gillis; E Benson; D Davies; V Esnault; R J Falk; E C Hagen; D Jayne; J C Jennette; B Paspaliaris; W Pollock; C Pusey; C O Savage; R Silvestrini; F van der Woude; J Wieslander; A Wiik
Journal:  Am J Clin Pathol       Date:  1999-04       Impact factor: 2.493

Review 6.  Infections and antineutrophil cytoplasmic antibodies: triggering mechanisms.

Authors:  Konstantin N Konstantinov; Constance J Ulff-Møller; Antonios H Tzamaloukas
Journal:  Autoimmun Rev       Date:  2014-11-04       Impact factor: 9.754

Review 7.  Position paper: Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis.

Authors:  Xavier Bossuyt; Jan-Willem Cohen Tervaert; Yoshihiro Arimura; Daniel Blockmans; Luis Felipe Flores-Suárez; Loïc Guillevin; Bernhard Hellmich; David Jayne; J Charles Jennette; Cees G M Kallenberg; Sergey Moiseev; Pavel Novikov; Antonella Radice; Judith Anne Savige; Renato Alberto Sinico; Ulrich Specks; Pieter van Paassen; Ming-Hui Zhao; Niels Rasmussen; Jan Damoiseaux; Elena Csernok
Journal:  Nat Rev Rheumatol       Date:  2017-09-14       Impact factor: 20.543

8.  Proteinase-3 antineutrophil cytoplasm antibody positivity in patients without primary systemic vasculitis.

Authors:  Stephen Paul McAdoo; Angela Hall; Jeremy Levy; Alan D Salama; Charles D Pusey
Journal:  J Clin Rheumatol       Date:  2012-10       Impact factor: 3.517

9.  Using antineutrophil cytoplasmic antibody testing to diagnose vasculitis: can test-ordering guidelines improve diagnostic accuracy?

Authors:  Lisa A Mandl; Daniel H Solomon; Ellison L Smith; Robert A Lew; Jeffrey N Katz; Robert H Shmerling
Journal:  Arch Intern Med       Date:  2002-07-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.